Table 1. Baseline clinical characteristics of the entire cohort based on the WBC count.
Variables | Cases [number, %] | Preoperative leukocytes [7×109/L, %] | ||
---|---|---|---|---|
Non-leukocytosis | Leukocytosis | P value | ||
Gender | 0.006 | |||
Female | 586 [19] | 477 [20] | 109 [15] | |
Male | 2,510 [81] | 1,911 [80] | 599 [85] | |
Age [years] | 0.732 | |||
<65 | 1,929 [62] | 1,484 [62] | 445 [63] | |
≥65 | 1,167 [38] | 904 [38] | 263 [37] | |
T stage | <0.001 | |||
T1 | 867 [28] | 761 [32] | 106 [15] | |
T2 | 402 [13] | 382 [16] | 20 [3] | |
T3 | 1,579 [51] | 1,141 [48] | 438 [62] | |
T4 | 248 [8] | 104 [4] | 144 [20] | |
Lymph node metastasis | 0.339 | |||
N0 | 1,238 [40] | 955 [40] | 283 [40] | |
N1 | 960 [31] | 748 [31] | 212 [30] | |
N2 | 650 [21] | 505 [21] | 145 [20] | |
N3 | 248 [8] | 180 [8] | 68 [10] | |
TNM stage | <0.001 | |||
I | 650 [21] | 537 [22] | 113 [16] | |
II | 743 [24] | 580 [24] | 163 [23] | |
III | 1,331 [43] | 1,019 [43] | 312 [44] | |
IV | 372 [12] | 252 [11] | 120 [17] | |
Tumor location | 0.239 | |||
Upper | 88 [3] | 73 [3] | 15 [2] | |
Middle | 2,234 [72] | 1,730 [72] | 504 [71] | |
Lower | 774 [25] | 585 [25] | 189 [27] | |
Tumor type | 0.309 | |||
Adenocarcinoma | 279 [9] | 222 [9] | 57 [8] | |
Squamous | 2,817 [91] | 2,166 [91] | 651 [92] | |
Tumor differentiation | 0.969 | |||
Well | 248 [8] | 190 [8] | 58 [8] | |
Moderate | 2,415 [78] | 1,865 [78] | 550 [78] | |
Poor | 433 [14] | 333 [14] | 100 [14] | |
Surgical procedure | 0.075 | |||
Open | 1,115 [36] | 880 [37] | 235 [33] | |
Video-assisted | 1,981 [64] | 1,508 [63] | 473 [67] | |
Postoperative chemotherapy | <0.001 | |||
Yes | 1,238 [40] | 945 [40] | 415 [60] | |
No | 1,858 [60] | 1,443 [60] | 293 [40] | |
Anesthesia | 0.383 | |||
General anesthesia | 791 [26] | 619 [26] | 172 [24] | |
General and epidural anesthesia | 2,305 [74] | 1,769 [74] | 536 [76] | |
Number of incisions | 0.499 | |||
1 | 49 [2] | 35 [1] | 14 [2] | |
2 | 2,718 [88] | 2,094 [88] | 624 [88] | |
3 | 329 [10] | 259 [11] | 70 [10] |